Axon Enterprise Inc tiene un precio objetivo de consenso de $682.45 basado en las calificaciones de 21 analistas. El máximo es $1000, emitido por B of A Securities el agosto 6, 2025. El mínimo es $309, emitido por Credit Suisse el mayo 10, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por Barclays, UBS y Goldman Sachs el noviembre 6, 2025, noviembre 5, 2025 y noviembre 5, 2025, respectivamente. Con un precio objetivo promedio de $704 entre Barclays, UBS y Goldman Sachs, hay una 19.51% upside implícita para Axon Enterprise Inc según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/06/2025 | 19.17% | Barclays | $861 → $702 | Maintains | Overweight | |||
11/05/2025 | 3.55% | UBS | $840 → $610 | Maintains | Neutral | |||
11/05/2025 | 35.8% | Goldman Sachs | $940 → $800 | Maintains | Buy | |||
11/05/2025 | 27.83% | Piper Sandler | $893 → $753 | Maintains | Overweight | |||
09/29/2025 | 40.05% | JMP Securities | $825 → $825 | Reiterates | Market Outperform → Market Outperform | |||
09/24/2025 | 51.59% | Piper Sandler | → $893 | Initiates | → Overweight | |||
09/24/2025 | 47.69% | Needham | $870 → $870 | Reiterates | Buy → Buy | |||
08/06/2025 | 69.76% | B of A Securities | $895 → $1000 | Maintains | Buy | |||
08/05/2025 | 35.8% | Northland Capital Markets | $640 → $800 | Maintains | Outperform | |||
08/05/2025 | 52.78% | Craig-Hallum | → $900 | Upgrade | Hold → Buy | |||
08/05/2025 | 45.14% | Raymond James | $645 → $855 | Maintains | Outperform | |||
08/05/2025 | 42.59% | UBS | $820 → $840 | Maintains | Neutral | |||
08/05/2025 | 47.69% | Needham | $820 → $870 | Maintains | Buy | |||
07/22/2025 | 40.05% | JMP Securities | $725 → $825 | Maintains | Market Outperform | |||
07/17/2025 | 44.29% | JP Morgan | $730 → $850 | Maintains | Overweight | |||
07/16/2025 | 39.2% | UBS | → $820 | Initiates | → Neutral | |||
07/08/2025 | — | Wolfe Research | — | Initiates | → Outperform | |||
06/04/2025 | 51.93% | B of A Securities | $750 → $895 | Maintains | Buy | |||
05/14/2025 | 40.9% | Goldman Sachs | $730 → $830 | Maintains | Buy | |||
05/09/2025 | 24.77% | Barclays | $726 → $735 | Maintains | Overweight | |||
05/08/2025 | 8.64% | Northland Capital Markets | $585 → $640 | Maintains | Outperform | |||
05/08/2025 | 27.32% | Needham | $600 → $750 | Maintains | Buy | |||
04/23/2025 | 1.85% | Needham | $600 → $600 | Reiterates | Buy → Buy | |||
02/27/2025 | 23.24% | Barclays | $585 → $726 | Maintains | Overweight | |||
02/26/2025 | -0.69% | Northland Capital Markets | $550 → $585 | Maintains | Outperform | |||
02/26/2025 | 23.07% | Citizens Capital Markets | $725 → $725 | Reiterates | Market Outperform → Market Outperform | |||
02/26/2025 | 1.85% | Needham | $600 → $600 | Reiterates | Buy → Buy | |||
02/20/2025 | 6.1% | Craig-Hallum | → $625 | Downgrade | Buy → Hold | |||
02/04/2025 | 23.07% | JMP Securities | $610 → $725 | Maintains | Market Outperform | |||
01/27/2025 | 18.83% | Goldman Sachs | $500 → $700 | Maintains | Buy | |||
01/08/2025 | 18.83% | TD Cowen | → $700 | Initiates | → Buy | |||
12/06/2024 | 35.8% | Baird | $600 → $800 | Maintains | Outperform | |||
12/03/2024 | 18.83% | Morgan Stanley | $500 → $700 | Upgrade | Equal-Weight → Overweight | |||
11/11/2024 | -0.69% | Barclays | $387 → $585 | Maintains | Overweight | |||
11/11/2024 | -6.63% | Northland Capital Markets | $365 → $550 | Maintains | Outperform | |||
11/08/2024 | 3.55% | JMP Securities | $500 → $610 | Maintains | Market Outperform | |||
11/08/2024 | 1.85% | Needham | $525 → $600 | Maintains | Buy | |||
11/08/2024 | 1.85% | Baird | $460 → $600 | Maintains | Outperform | |||
11/04/2024 | -21.91% | Baird | $400 → $460 | Maintains | Outperform | |||
10/31/2024 | -15.12% | JMP Securities | $430 → $500 | Maintains | Market Outperform | |||
10/23/2024 | -25.14% | Goldman Sachs | $385 → $441 | Maintains | Buy | |||
10/22/2024 | -10.88% | Needham | $400 → $525 | Maintains | Buy | |||
09/12/2024 | -27.01% | JMP Securities | $375 → $430 | Maintains | Market Outperform | |||
09/10/2024 | -32.1% | Baird | $360 → $400 | Maintains | Outperform | |||
09/09/2024 | -36.34% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
08/08/2024 | -38.04% | Northland Capital Markets | $330 → $365 | Maintains | Outperform | |||
08/07/2024 | -36.34% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
08/07/2024 | -34.3% | Barclays | $381 → $387 | Maintains | Overweight | |||
08/07/2024 | -36.17% | Craig-Hallum | $370 → $376 | Maintains | Buy | |||
08/07/2024 | -38.89% | Baird | $355 → $360 | Maintains | Outperform | |||
08/07/2024 | -32.1% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
07/17/2024 | -34.64% | Jefferies | → $385 | Initiates | → Buy | |||
07/17/2024 | -35.49% | B of A Securities | → $380 | Initiates | → Buy | |||
05/08/2024 | -35.32% | Barclays | $308 → $381 | Maintains | Overweight | |||
05/07/2024 | -36.34% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
05/07/2024 | -32.1% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/07/2024 | -37.19% | Craig-Hallum | $325 → $370 | Maintains | Buy | |||
05/01/2024 | -36.34% | JMP Securities | $320 → $375 | Maintains | Market Outperform | |||
04/26/2024 | -47.38% | Morgan Stanley | $285 → $310 | Maintains | Equal-Weight | |||
04/24/2024 | -32.1% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
04/11/2024 | -38.04% | JP Morgan | $330 → $365 | Maintains | Overweight | |||
04/10/2024 | -32.1% | Needham | $315 → $400 | Maintains | Buy | |||
03/13/2024 | -35.49% | Argus Research | → $380 | Initiates | → Buy | |||
02/29/2024 | -47.72% | Barclays | $296 → $308 | Maintains | Overweight | |||
02/28/2024 | -49.07% | Northland Capital Markets | $235 → $300 | Maintains | Outperform | |||
02/28/2024 | -51.62% | Morgan Stanley | $250 → $285 | Maintains | Equal-Weight | |||
02/28/2024 | -42.45% | Goldman Sachs | $297 → $339 | Maintains | Buy | |||
02/28/2024 | -43.98% | JP Morgan | $285 → $330 | Maintains | Overweight | |||
02/28/2024 | -46.53% | Needham | $240 → $315 | Maintains | Buy | |||
02/22/2024 | -49.07% | Baird | $260 → $300 | Maintains | Outperform | |||
02/06/2024 | -51.62% | JMP Securities | $250 → $285 | Maintains | Market Outperform | |||
02/02/2024 | -59.26% | Needham | $240 → $240 | Reiterates | Buy → Buy | |||
01/02/2024 | -49.75% | Barclays | $247 → $296 | Maintains | Overweight | |||
11/08/2023 | -60.45% | Raymond James | $223 → $233 | Maintains | Outperform | |||
09/29/2023 | -60.11% | JMP Securities | → $235 | Reiterates | Market Outperform → Market Outperform | |||
08/22/2023 | -60.96% | Morgan Stanley | → $230 | Initiates | → Equal-Weight | |||
08/11/2023 | -60.11% | Northland Capital Markets | $227 → $235 | Maintains | Outperform | |||
08/09/2023 | -59.43% | Barclays | $256 → $239 | Maintains | Overweight | |||
08/09/2023 | -59.26% | Needham | → $240 | Reiterates | Buy → Buy | |||
05/11/2023 | -59.26% | Baird | $237 → $240 | Maintains | Outperform | |||
05/11/2023 | -59.94% | JP Morgan | → $236 | Upgrade | Neutral → Overweight | |||
05/10/2023 | -60.11% | JMP Securities | → $235 | Reiterates | → Market Outperform | |||
05/10/2023 | -47.55% | Credit Suisse | $300 → $309 | Maintains | Outperform | |||
05/10/2023 | -59.26% | Needham | → $240 | Reiterates | → Buy | |||
05/10/2023 | -56.54% | Barclays | $222 → $256 | Maintains | Overweight | |||
04/14/2023 | -60.11% | JMP Securities | → $235 | Reiterates | → Market Outperform | |||
04/13/2023 | -59.26% | Needham | → $240 | Reiterates | → Buy | |||
04/11/2023 | -49.07% | Credit Suisse | $237 → $300 | Maintains | Outperform | |||
03/08/2023 | -55.35% | Goldman Sachs | → $263 | Initiates | → Buy | |||
03/02/2023 | -62.31% | Barclays | $177 → $222 | Maintains | Overweight | |||
03/02/2023 | -61.97% | JP Morgan | → $224 | Downgrade | Overweight → Neutral | |||
03/01/2023 | -59.77% | Baird | $200 → $237 | Maintains | Outperform | |||
03/01/2023 | -59.77% | Credit Suisse | $200 → $237 | Maintains | Outperform | |||
03/01/2023 | -59.26% | Needham | → $240 | Reiterates | → Buy | |||
02/17/2023 | -62.14% | Raymond James | → $223 | Downgrade | Strong Buy → Outperform | |||
02/01/2023 | -60.11% | JMP Securities | $195 → $235 | Maintains | Market Outperform | |||
01/10/2023 | -66.05% | Credit Suisse | $152 → $200 | Maintains | Outperform | |||
12/13/2022 | -73.69% | Morgan Stanley | $130 → $155 | Maintains | Equal-Weight |
El último precio objetivo de Axon Enterprise (NASDAQ:AXON) fue comunicado por Barclays el noviembre 6, 2025. La firma de analistas fijó un precio objetivo para $702.00 que espera AXON a rise dentro de 12 meses (un posible 19.17% upside). 35 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Axon Enterprise (NASDAQ:AXON) fue proporcionada por Barclays, y Axon Enterprise mantuvo su overweight calificación.
La última revisión al alza de Axon Enterprise Inc se produjo en agosto 5, 2025, cuando Craig-Hallum elevó su precio objetivo a $900. Craig-Hallum anteriormente tenía a hold para Axon Enterprise Inc.
La última revisión a la baja de Axon Enterprise Inc se produjo en febrero 20, 2025, cuando Craig-Hallum cambió su precio objetivo de N/A a $625 para Axon Enterprise Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Axon Enterprise, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Axon Enterprise se registró el noviembre 6, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 6, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Axon Enterprise (AXON) fue un mantuvo con un precio objetivo de $861.00 a $702.00. El precio actual al que cotiza Axon Enterprise (AXON) es de $589.08, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.